Skip to main content
49°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
Next >
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Mad Money
Markets
Stock Picks
From
CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
October 31, 2024
Tags
Earnings
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Apple Inc
Chipotle Mexican Grill Inc
Peloton Interactive Inc
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
LILLY DRN
Royal Caribbean Cruises Ltd
Investing
From
CNBC.com News
5 things to know before the stock market opens Friday
September 27, 2024
Tags
5 Things to Know
Business
Government and politics
From
CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Eli Lilly and Co
Health care industry
AstraZeneca PLC
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Health care industry
Politics
Bristol/Myers Squibb Co
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Breaking news
Health & Science
Business News
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Novartis AG
Health care industry
Johnson & Johnson
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
Health care industry
Earnings
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Merck & Co Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
July 22, 2024
Tags
CrowdStrike Holdings Inc
Investment strategy
Politics
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Peloton Interactive Inc
Personnel
Bristol/Myers Squibb Co
From
CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
June 24, 2024
Tags
Rubrik Inc
Bristol/Myers Squibb Co
Investment strategy
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Biotech and Pharmaceuticals
Merck & Co Inc
Pfizer Inc
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
Mad Money
T Rowe Price Group Inc
S&P 500
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Pharmaceuticals
Breaking News: Investing
Fusion Pharmaceuticals Inc
From
CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
Tags
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
Johnson & Johnson
From
CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Bristol/Myers Squibb Co
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
General Electric Co
Hasbro Inc
Atlassian Corp
From
CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Healthy Returns
Johnson & Johnson
Health care industry
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
Tags
Breaking News: Politics
US: News
Companies
From
CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
Tags
Prices
Breaking news
Pharmaceuticals
From
CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
Tags
Earnings
Technology
Exxon Mobil Corp
From
CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
February 02, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Biotech and Pharmaceuticals
Merck & Co Inc
Bristol/Myers Squibb Co
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
General Motors Co
Investing
GSK plc
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Amgen Inc
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.